Patents by Inventor Lucile A. Gillett

Lucile A. Gillett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PSMCs As Modifiers of the RB Pathway and Methods of Use
    Publication number: 20120107827
    Abstract: Human PSMC genes are identified as modulators of the RB pathway, and thus are therapeutic targets for disorders associated with defective RB function. Methods for identifying modulators of RB, comprising screening for agents that modulate the activity of PSMC are provided.
    Type: Application
    Filed: October 12, 2011
    Publication date: May 3, 2012
    Applicant: EXELIXIS, INC.
    Inventors: ALBERT K. TAI, CHUNYAN SONG, MICHAEL MARTIN OLLMANN, LUCILE A. GILLETT, JOANNE I. ADAMKEWICZ, KIM LICKTEIG
  • Psmcs as Modifiers of the Rb Pathway and Methods of Use
    Publication number: 20090013420
    Abstract: Human PSMC genes are identified as modulators of the RB pathway, and thus are therapeutic targets for disorders associated with defective RB function. Methods for identifying modulators of RB, comprising screening for agents that modulate the activity of PSMC are provided.
    Type: Application
    Filed: August 6, 2003
    Publication date: January 8, 2009
    Inventors: Albert K. Tai, Chunyan Song, Michael Martin Ollmann, Lucile A. Gillett, Joanne I. Adamkewicz, Kim Lickteig
  • Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use
    Patent number: 6511824
    Abstract: Tandem pore domain weak inward rectifying K+ (TWIK) channel nucleic acids and proteins that have been isolated from Drosophila melanogaster and Leptinotarsa are described. The TWIK channel nucleic acids and proteins can be used to genetically modify metazoan invertebrate organisms, such as insects, coelomates, and pseudocoelomates, or cultured cells, resulting in TWIK channel expression or mis-expression. The genetically modified organisms or cells can be used in screening assays to identify candidate compounds which are potential pesticidal agents or therapeutics that interact with TWIK channel proteins. They can also be used in methods for studying TWIK channel activity and identifying other genes that modulate the function of, or interact with, the TWIK channel gene.
    Type: Grant
    Filed: July 28, 1999
    Date of Patent: January 28, 2003
    Assignee: Exelixis, Inc.
    Inventors: Andrew Roy Buchman, Christian Burks, Helen Louise Francis-Lang, Lucile A. Gillett, Jonathan Cagampang Heller, Casey Casimir Kopczynski, Jonathan Scott Margolis, Darren Mark Platt, Bindu Priya Reddy, Candace Swimmer, John W. Winslow, Yuling Luo